LCS
PEAR

Levin Capital Strategies’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Levin Capital Strategies’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,000
Closed -$199K – 414
2021
Q3 		$199K Sell
20,000
-49,999
-71% -$497K 0.02% 256
2021
Q2 		$692K Buy
+69,999
New +$692K 0.07% 127